Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Narita
Clinical trial register · Japan

Clinical Trials in Narita, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Narita

19 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Eli Lilly and Company
Phase 2
120
Hachiōji, Kamakura-shi, Naka, Narita
2026-08-27
Recruiting
Insmed Incorporated
Phase 3
344
Narita, Yokohama
2026-07-20
Recruiting
argenx
Phase 2
70
Tsukuba, Kawasaki-shi, Sendai, Hanamaki, Narita
2025-12-19
Recruiting
argenx
Observational
70
Tsukuba, Kawasaki-Shi, Sendai, Hanamaki, Narita
2025-12-19
Recruiting
Eli Lilly and Company
Phase 2
531
Chūōku, Habikino, Iizuka, Kagoshima, Kanazawa, Katsushika-ku, Nagoya, Narita
2025-10-22
Recruiting
Pfizer
Phase 3
300
Toyoake, Narita, Iizuka, Izumisano, Hachiōji, Shinjuku, Tachikawa, Fukuoka
2025-07-14
Not yet open
International University of Health and Welfare
Not applicable
20
Narita
2025-06-01
Active, closed
Sanofi
Phase 3
231
Ichikawa, Narita, Isehara, Odawara, Yokohama, Suwa, Kusatsu, Fukui
2025-02-12
Recruiting
Pfizer
Phase 3
2,330
Kasugai, Narita, Fukuoka, Okawa-shi, Sapporo, Himeji, Koga-shi, Tsuchiura
2024-12-08
Recruiting
Chiba University
Phase 4
160
Toyoake, Asahi, Chiba, Ichihara, Kamogawa, Narita, Maebashi, Hiragi
2024-11-15
Recruiting
Takeda
Phase 3
24
Narita, Kashihara, Beppu, Nagasaki
2024-11-06
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Nagakute, Nagoya, Narita, Matsuyama, Fukuoka, Hiroshima, Kobe, Hitachi
2024-10-01
Active, closed
argenx
Phase 3
141
Chūōku, Fukuoka, Hanamaki-shi, Hiroshima, Kawagoe, Kyoto, Narita, Sapporo
2024-09-18
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Chiba, Narita, Sapporo, Nishinomiya, Hanamaki, Sendai, Suita, Higashi-Matsuyama
2024-07-31
Active, closed
Bristol-Myers Squibb
Phase 1/2
83
Anjo-shi, Nagoya, Toyohashi, Kamogawa, Kashiwa, Narita, Iizuka, Kitakyushu-shi
2023-11-20
Active, closed
Sound Wave Innovation CO., LTD.
Phase 3
220
Nagoya, Ōbu, Narita, Fukuoka, Hiroshima, Sapporo, Toride, Kanazawa
2023-10-31
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Narita, Matsuyama, Gifu, Kobe, Isehara, Suita, Shinjuku Ku, tabashi City
2022-12-30
Active, closed
Novartis Pharmaceuticals
Phase 2
36
Narita, Kurume, Ohtake, Nishinomiya, Kanazawa, Isehara, Yokohama, Sendai
2021-05-25
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-japan/city/narita

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Narita.

How many clinical trials are recruiting in Narita?

10 of the 19 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Narita), 19 studies
PhaseStudiesRecruitingShare
Phase 311557.9%
Phase 24321.1%
Not applicable105.3%
Observational115.3%
Phase 1/2105.3%
Phase 4115.3%

Most active sponsors

Lead sponsors with the most studies (Narita)
Lead sponsorStudiesRecruiting
argenx32
Novartis Pharmaceuticals30
Eli Lilly and Company22
Pfizer22
Bristol-Myers Squibb10
Chiba University11
Ferring Pharmaceuticals11
Insmed Incorporated11
International University of Health and Welfare10
Janssen Research & Development, LLC10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.